JEENESS MACATANGAY: Open Payments
NPI 1659870509 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$211 in 8 payments from 6 companies in 2025. Trend: 2023 $337 · 2024 $377 · 2025 $211
Food & beverage: $115Education: $97
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $114 |
| Janssen Biotech, Inc. | 2 | $34 |
| Rigel Pharmaceuticals, Inc. | 1 | $18 |
| Geron Corporation | 1 | $17 |
| Adaptive Biotechnologies Corporation | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: TAVALISSE, VERZENIO, TALVEY, TECVAYLI, RYTELO, clonoSEQ, IMBRUVICA.
Industry payments across NY — which companies pay providers there.
